Peptide-based imaging agents for cancer detection

X Sun, Y Li, T Liu, Z Li, X Zhang, X Chen - Advanced drug delivery reviews, 2017 - Elsevier
Selective receptor-targeting peptide based agents have attracted considerable attention in
molecular imaging of tumor cells that overexpress corresponding peptide receptors due to …

Clinical applications of Gallium-68

SR Banerjee, MG Pomper - Applied Radiation and Isotopes, 2013 - Elsevier
Gallium-68 is a positron-emitting radioisotope that is produced from a 68Ge/68Ga generator.
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …

[HTML][HTML] Radiolabeled peptides: valuable tools for the detection and treatment of cancer

M Fani, HR Maecke, SM Okarvi - Theranostics, 2012 - ncbi.nlm.nih.gov
Human cancer cells overexpress many peptide receptors as molecular targets.
Radiolabeled peptides that bind with high affinity and specificity to the receptors on tumor …

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

P Antunes, M Ginj, H Zhang, B Waser, RP Baum… - European journal of …, 2007 - Springer
Purpose Gallium-68 is a metallic positron emitter with a half-life of 68 min that is ideal for the
in vivo use of small molecules, such as [68 Ga-DOTA, Tyr 3] octreotide, in the diagnostic …

Overview of radiolabeled somatostatin analogs for cancer imaging and therapy

R Eychenne, C Bouvry, M Bourgeois, P Loyer… - Molecules, 2020 - mdpi.com
Identified in 1973, somatostatin (SST) is a cyclic hormone peptide with a short biological half-
life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five …

Technetium‐99m radiochemistry for pharmaceutical applications

D Papagiannopoulou - Journal of Labelled Compounds and …, 2017 - Wiley Online Library
Technetium‐99m (99mTc) is a widely used radionuclide, and the development of 99mTc
imaging agents continues to be in demand. This overview discusses basic principles of …

Bombesin receptor antagonists may be preferable to agonists for tumor targeting

R Cescato, T Maina, B Nock… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Two bombesin analogs, Demobesin 4 and Demobesin 1, were characterized in vitro as
gastrin-releasing peptide (GRP) receptor agonist and antagonist, respectively, and were …

Peptide‐based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases

SM Okarvi - Medicinal research reviews, 2004 - Wiley Online Library
An Erratum has been published for this article in Medicinal Research Reviews 2004; 24: 685–
686. Small synthetic receptor‐binding peptides are the agents of choice for diagnostic …

Molecular imaging targeting peptide receptors

M Schottelius, HJ Wester - Methods, 2009 - Elsevier
Overexpressed neuropeptide receptors allow tumor visualization using eg radiolabeled
peptidic receptor ligands and positron emission tomography (PET) or single photon …

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

B Nock, A Nikolopoulou, E Chiotellis, G Loudos… - European journal of …, 2003 - Springer
Demobesin 1 is a potent new GRP-R-selective bombesin (BN) analogue containing an open
chain tetraamine chelator for stable technetium-99m binding. Following a convenient …